4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-047221
EVP & Chief Strategy Officer gave up 382 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Soffer Gad EVP & Chief Strategy Officer | 2018-08-15 | Shares withheld for taxes | −382 | $35.90 | $13,714 | 266,124 | D |
Loading xslF345X03/doc4.xml…